GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (OTCPK:ATVBY) » Definitions » Cyclically Adjusted Book per Share

Active Biotech AB (Active Biotech AB) Cyclically Adjusted Book per Share : $0.00 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Active Biotech AB Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Active Biotech AB's adjusted book value per share for the three months ended in Mar. 2024 was $0.015. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Active Biotech AB's average Cyclically Adjusted Book Growth Rate was -28.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -20.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -14.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Active Biotech AB was -6.70% per year. The lowest was -20.30% per year. And the median was -12.45% per year.

As of today (2024-06-12), Active Biotech AB's current stock price is $0.00. Active Biotech AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.00. Active Biotech AB's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Active Biotech AB was 2.17. The lowest was 0.31. And the median was 0.80.


Active Biotech AB Cyclically Adjusted Book per Share Historical Data

The historical data trend for Active Biotech AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Cyclically Adjusted Book per Share Chart

Active Biotech AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Active Biotech AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Active Biotech AB's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Active Biotech AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Active Biotech AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Active Biotech AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Active Biotech AB's Cyclically Adjusted PB Ratio falls into.



Active Biotech AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Active Biotech AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.015/132.2054*132.2054
=0.015

Current CPI (Mar. 2024) = 132.2054.

Active Biotech AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.582 100.432 0.766
201409 0.443 100.161 0.585
201412 0.709 100.225 0.935
201503 0.455 99.950 0.602
201506 0.377 99.995 0.498
201509 0.344 100.228 0.454
201512 0.236 100.276 0.311
201603 0.221 100.751 0.290
201606 0.204 101.019 0.267
201609 0.182 101.138 0.238
201612 0.205 102.022 0.266
201703 0.195 102.022 0.253
201706 0.174 102.752 0.224
201709 0.178 103.279 0.228
201712 0.072 103.793 0.092
201803 0.063 103.962 0.080
201806 0.093 104.875 0.117
201809 0.084 105.679 0.105
201812 0.076 105.912 0.095
201903 0.067 105.886 0.084
201906 0.061 106.742 0.076
201909 0.052 107.214 0.064
201912 0.044 107.766 0.054
202003 0.034 106.563 0.042
202006 0.028 107.498 0.034
202009 0.023 107.635 0.028
202012 0.021 108.296 0.026
202103 0.079 108.360 0.096
202106 0.068 108.928 0.083
202109 0.056 110.338 0.067
202112 0.040 112.486 0.047
202203 0.025 114.825 0.029
202206 0.013 118.384 0.015
202209 0.035 122.296 0.038
202212 0.026 126.365 0.027
202303 0.017 127.042 0.018
202306 0.009 129.407 0.009
202309 0.001 130.224 0.001
202312 0.023 131.912 0.023
202403 0.015 132.205 0.015

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Active Biotech AB  (OTCPK:ATVBY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Active Biotech AB was 2.17. The lowest was 0.31. And the median was 0.80.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Active Biotech AB Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Active Biotech AB's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Active Biotech AB (Active Biotech AB) Business Description

Industry
Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (Active Biotech AB) Headlines

No Headlines